Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 12/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 10/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.47 |
| ▸ | CXCR6 | O00574 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6874142 | 1.00 | MCHR1 (0.56) | MCHR1ADRA2ASMN1; SMN2HTR1AADRA1A | |
| SCHEMBL6874537 | 0.93 | MCHR1 (0.56) | MCHR1ADRA2ASMN1; SMN2HTR1AADRA1A | |
| SCHEMBL6877264 | 0.91 | MCHR1 (0.54) | MCHR1ADRA2ASMN1; SMN2HTR1AADRA1A | |
| SCHEMBL6877272 | 0.91 | MCHR1 (0.54) | MCHR1ADRA2ASMN1; SMN2HTR1AADRA1A | |
| SCHEMBL6467582 | 0.89 | MCHR1 (0.70) | MCHR1ADRA2AHTR1AADRA1AHRH1 | |
| SCHEMBL6467597 | 0.89 | MCHR1 (0.70) | MCHR1ADRA2AHTR1AADRA1AHRH1 | |
| SCHEMBL6463284 | 0.88 | SMN1; SMN2 (0.57) | MCHR1ADRA2ASMN1; SMN2CXCR6MAPT | |
| SCHEMBL6463274 | 0.88 | SMN1; SMN2 (0.57) | MCHR1ADRA2ASMN1; SMN2CXCR6MAPT | |
| SCHEMBL6467397 | 0.87 | MAPT (0.45) | MCHR1ADRA2ASMN1; SMN2MAPT | |
| SCHEMBL6467407 | 0.87 | MAPT (0.45) | MCHR1ADRA2ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | disclosed |